Business
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer
SANTA CLARA, Calif., January 22, 2026--HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer
About this update from Heartbeam, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/cb71c569d312b45258ac857cb136e6a7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ysnkgwdGLdvQMmwIywmzRQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/cb71c569d312b45258ac857cb136e6a7","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/h7mEAhUJAy33Vco.24bYfg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/cb71c569d312b45258ac857cb136e6a7","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Brings more than 25 years of experience in building and scaling groundbreaking cardiovascular technologies","length":106,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Will initially focus on launching the Company’s FDA-cleared 12-lead ECG system for arrhythmia assessment","length":104,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Will lead the Company’s broader commercialization strategy across key growth initiatives, including heart attack detection and the 12-lead ECG extended-wear patch","length":162,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":372,"olType":false},{"type":"text","content":"SANTA CLARA, Calif., January 22, 2026--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the appointment of Bryan Humbarger as Chief Commercial Officer, effective January 22, 2026. In this newly created role, Mr. Humbarger will lead commercial strategy and execution across the Company’s key growth initiatives. These include the limited launch of the recently cleared HeartBeam System for arrhythmia assessment, heart attack detection indication and 12-lead ECG extended wear patch monitor.","length":612,"tagName":"p"},{"type":"text","content":"He will lead outreach to the cardiology community, focusing on developing partnerships with channel partners and prominent cardiology practices who have proactively signaled strong interest in adopting HeartBeam’s technology. This will enable the Company to ef...